User profiles for Juan M Carreño
Juan Manuel Carreño QuirozIcahn School of Medicine at Mount Sinai Verified email at ciencias.unam.mx Cited by 2957 |
[HTML][HTML] Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
The Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was initially identified in November 2021 in South Africa and Botswana, as well as in …
was initially identified in November 2021 in South Africa and Botswana, as well as in …
[HTML][HTML] SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
[HTML][HTML] Defining the risk of SARS-CoV-2 variants on immune protection
…, TL Bricker, L Brown, WJ Buchser, JM Carreño… - Nature, 2022 - nature.com
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …
variants jeopardizes the protective antiviral immunity induced after infection or …
[HTML][HTML] A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled …
…, D Bhavsar, C Bliss, C Capuano, JM Carreño… - Nature medicine, 2021 - nature.com
Seasonal influenza viruses constantly change through antigenic drift and the emergence of
pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza …
pandemic influenza viruses through antigenic shift is unpredictable. Conventional influenza …
[HTML][HTML] SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
…, D Floda, K Srivastava, C Gleason, JM Carreño… - Nature …, 2022 - nature.com
Immune responses at the respiratory mucosal interface are critical to prevent respiratory
infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) …
infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) …
[HTML][HTML] Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants
…, S Schaefer, G Patel, J Polanco, JM Carreño… - Nature …, 2023 - nature.com
Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have
been reported in immune-compromised individuals and people undergoing immune-…
been reported in immune-compromised individuals and people undergoing immune-…
[HTML][HTML] Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine
…, DA Bielak, JM Carreño… - … England Journal of …, 2021 - Mass Medical Soc
Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …
[HTML][HTML] Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Y Ju, JM Carreño, V Simon, K Dawson… - Nature Reviews …, 2023 - nature.com
The successful mRNA vaccines against COVID-19 contain polyethylene glycol (PEG) to
stabilize the lipid nanoparticles. Recent data show that PEG-specific antibodies can be induced …
stabilize the lipid nanoparticles. Recent data show that PEG-specific antibodies can be induced …
Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses
Combined vaccine formulations targeting not only hemagglutinin but also other influenza virus
antigens could form the basis for a universal influenza virus vaccine that has the potential …
antigens could form the basis for a universal influenza virus vaccine that has the potential …
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
Although mRNA vaccines encoding the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants …
coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants …